Levopidon (Levomethadone Hydrochloride)

Levomethadone hydrochloride is a full agonist at the μ‑opioid receptor. By binding to this receptor, it activates pathways that produce analgesia and reduce the neurochemical changes associated with opioid withdrawal, thereby stabilizing opioid‑dependent patients and relieving severe pain.

The appropriate dose of Levopidon is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for levomethadone hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Levopidon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levopidon (levomethadone) is a synthetic opioid similar in effect to methadone but with a different stereoisomeric composition, which may influence its pharmacokinetic profile. Compared with buprenorphine, levomethadone is a full μ‑opioid agonist, offering stronger analgesia but also a higher risk of respiratory depression, requiring careful monitoring.

Levopidon should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, and store it away from direct sunlight or heat sources to maintain stability.

Levopidon is administered orally, typically as a tablet taken with water. The exact dosing schedule and any special administration instructions should be provided by the prescribing healthcare professional.

The most serious risks include respiratory depression, which can be life‑threatening, and cardiac arrhythmias due to QT interval prolongation. Severe allergic reactions and adrenal insufficiency are also rare but critical adverse events that require immediate medical attention.

Levopidon should be avoided in individuals with known hypersensitivity to levomethadone or any component of the formulation, in patients with severe respiratory insufficiency, uncontrolled cardiac arrhythmias, or in those taking contraindicated medications such as other strong opioids or MAO inhibitors without appropriate medical supervision.